| mRNA |
BAY 61-3606 |
GDSC1000 |
pan-cancer |
AAC |
0.0029 |
0.9 |
| mRNA |
PI-103 |
CTRPv2 |
pan-cancer |
AAC |
-0.003 |
0.9 |
| mRNA |
Sorafenib |
FIMM |
pan-cancer |
AAC |
0.016 |
0.9 |
| mRNA |
BRD-K27986637 |
CTRPv2 |
pan-cancer |
AAC |
0.006 |
0.9 |
| mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0027 |
0.9 |
| mRNA |
BRD-K75293299 |
CTRPv2 |
pan-cancer |
AAC |
0.006 |
0.9 |
| mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0028 |
0.9 |
| mRNA |
Zebularine |
CTRPv2 |
pan-cancer |
AAC |
-0.0026 |
0.9 |
| mRNA |
lapatinib |
UHNBreast |
pan-cancer |
AAC |
0.022 |
0.9 |
| mRNA |
MLN2480 |
CTRPv2 |
pan-cancer |
AAC |
-0.0039 |
0.9 |